Shell Asset Management Co. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 9.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 67,036 shares of the healthcare conglomerate’s stock after purchasing an additional 5,733 shares during the quarter. UnitedHealth Group comprises about 0.7% of Shell Asset Management Co.’s portfolio, making the stock its 20th biggest position. Shell Asset Management Co.’s holdings in UnitedHealth Group were worth $33,661,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of UNH. Outfitter Financial LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $25,000. Blue Bell Private Wealth Management LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $29,000. Annapolis Financial Services LLC grew its holdings in shares of UnitedHealth Group by 57.9% in the third quarter. Annapolis Financial Services LLC now owns 90 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 33 shares in the last quarter. Stuart Chaussee & Associates Inc. grew its holdings in shares of UnitedHealth Group by 55.6% in the fourth quarter. Stuart Chaussee & Associates Inc. now owns 70 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 25 shares in the last quarter. Finally, Level Financial Advisors Inc. bought a new position in UnitedHealth Group during the fourth quarter valued at $45,000. 86.07% of the stock is currently owned by institutional investors and hedge funds.
Shares of UNH traded down $15.87 during trading hours on Friday, reaching $508.55. 2,873,166 shares of the stock traded hands, compared to its average volume of 2,999,332. The company has a current ratio of 0.78, a quick ratio of 0.79 and a debt-to-equity ratio of 0.54. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The company’s 50-day moving average price is $507.83 and its two-hundred day moving average price is $480.86. The company has a market cap of $477.50 billion, a P/E ratio of 27.84, a price-to-earnings-growth ratio of 1.60 and a beta of 0.88.
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 22nd. Shareholders of record on Monday, March 14th were paid a $1.45 dividend. This represents a $5.80 annualized dividend and a yield of 1.14%. The ex-dividend date of this dividend was Friday, March 11th. UnitedHealth Group’s payout ratio is currently 31.75%.
Several equities research analysts have issued reports on the company. Raymond James increased their target price on UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, April 19th. Barclays raised their target price on UnitedHealth Group from $495.00 to $565.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 30th. StockNews.com began coverage on UnitedHealth Group in a research note on Thursday, March 31st. They issued a “strong-buy” rating on the stock. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $570.00 to $577.00 and gave the stock an “overweight” rating in a report on Monday, April 18th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $482.00 to $549.00 and gave the stock a “buy” rating in a report on Monday, April 18th. Two equities research analysts have rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $550.17.
In other news, Director Richard T. Burke sold 6,000 shares of the company’s stock in a transaction dated Friday, February 25th. The shares were sold at an average price of $470.38, for a total transaction of $2,822,280.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Paul R. Garcia purchased 2,146 shares of the business’s stock in a transaction that occurred on Tuesday, February 22nd. The shares were purchased at an average price of $464.97 per share, for a total transaction of $997,825.62. The disclosure for this purchase can be found here. In the last quarter, insiders sold 18,000 shares of company stock worth $8,776,840. Corporate insiders own 0.55% of the company’s stock.
UnitedHealth Group Company Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- O’Reilly Automotive Hits A Pothole
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.